PS
Pete Stavropoulos Cantor Fitzgerald Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
6
Avg Return
Past Year
Past Year
59%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
66.7%
Neutral
33.3%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Overweight
Initiated
| – | – | 1 | -47% |
0
%
| 18 Dec ‘25 4 months ago |
|
|
|
Overweight
Initiated
| $18 |
119%
upside
| 1 | +21% |
0
%
| 24 Oct ‘25 6 months ago |
|
|
|
Neutral
Downgraded
| – | – | 1 | -19% |
–
| 22 Oct ‘25 6 months ago |
|
|
|
Neutral
Downgraded
| – | – | 1 | – |
–
| 7 Jul ‘25 9 months ago |
|
|
|
Overweight
Assumed
| – | – | 1 | +183% |
0
%
| 2 Jul ‘25 9 months ago |
|
|
|
Overweight
Maintained
| $100 |
165%
upside
| 1 | +81% |
0
%
| 7 May ‘25 11 months ago |
|